Tag: Dilip Sanghvi
Sun Pharma features among top 5% of global pharma companies in...
780 companies have qualified for inclusion in The Sustainability Yearbook 2025 globally
Sun Pharma initiates Phase II clinical trial of first phytopharma drug...
Clinical trial of the drug that has shown anti-SARS-CoV-2 effects in in-vitro studies conducted in collaboration with ICGEB will be conducted across 12 centers in India in 210 patients; results expected by October 2020.............................
Sun Pharma achieves breaking results for its Psoriasis drug
The company has achieved primary end point in both Phase-3 studies in patients with moderate-to-severe plaque Psoriasis...